Atorvastatin in patients with type 1 diabetes and dyslipidaemia.

Trial Profile

Atorvastatin in patients with type 1 diabetes and dyslipidaemia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2011

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Dyslipidaemias; Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Dec 2011 Trial location (Sweden) added as reported by ClinicalTrials.gov.
    • 22 Dec 2011 Actual initiation date (Jan 2005) added as reported by ClinicalTrials.gov.
    • 22 Dec 2011 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top